Subacute Liver Failure Following Gene Replacement Therapy for Spinal Muscular Atrophy Type 1
- 1 October 2020
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 225, 252-258.e1
Abstract
No abstract availableKeywords
Funding Information
- Agency for Healthcare Research and Quality
This publication has 49 references indexed in Scilit:
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia BNew England Journal of Medicine, 2011
- Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimensEuropean Journal of Human Genetics, 2011
- Adeno-Associated Virus Antibody Profiles in Newborns, Children, and AdolescentsClinical and Vaccine Immunology, 2011
- Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophiliaGene Therapy, 2011
- The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9–dependent innate immune responses in the liverBlood, 2011
- RETRACTED ARTICLE: Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMNNature Biotechnology, 2010
- Proteasome Inhibitors Decrease AAV2 Capsid derived Peptide Epitope Presentation on MHC Class I Following TransductionMolecular Therapy, 2010
- The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in miceJournal of Clinical Investigation, 2009
- Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectorsJournal of Clinical Investigation, 2009
- Acute liver failure in children: The first 348 patients in the pediatric acute liver failure study groupThe Journal of Pediatrics, 2006